REGITINE
LOE ApproachingNDAINJECTIONINJECTABLEPriority Review
Approved
Jan 1952
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 10h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
REGITINE is an injectable small-molecule drug approved by Novartis in 1952 for acute hypertensive crises and pheochromocytoma management. The product is a classic vasodilator indicated for emergency blood pressure control in specific endocrine and surgical contexts. Its mechanism centers on alpha-adrenergic blockade to rapidly reduce systemic vascular resistance.
LOE Approaching
Product nearing loss-of-exclusivity with minimal current market presence; teams are likely focused on lifecycle extension or strategic de-emphasis rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
REGITINE represents a mature, niche portfolio asset with minimal linked job opportunities and likely declining headcount. Roles associated with this product typically involve specialty-care relationships, clinical protocol support, and regulatory maintenance rather than commercial growth initiatives.
Product Manager (specialty/niche)Medical Science Liaison
Worked on REGITINE at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.